Multiple system atrophy (MSA) is a neurodegenerative disorder with limited treatment options. However, recent research has yielded potential developments into new therapeutic approaches. Current focus centers on targeting the underlying pathophysiology of MSA. One strategy under investigation involves pharmacological interventions to influence the